NovoCure Ltd — Director's Dealing 2017

Jun 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-06-21

Reporting Person: Kirson Eilon D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-21	Ordinary Shares	S	66361	$16.775	Disposed	222722	Direct

Footnotes

F1: On June 21, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 66,361 shares in multiple trades at prices ranging from $16.60 to $17.50. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.